The impact of altered p53 dosage on hematopoietic stem cell dynamics during aging.

A temporal decline in tissue stem cell functionality may be a key component of mammalian aging. The tumor suppressor p53 has recently been implicated as a potential regulator of aging. We examined age-associated hematopoietic stem cell (HSC) dynamics in mice with varying p53 activities. Reduced p53 activity in p53+/- mice was associated with higher numbers of proliferating hematopoietic stem and progenitor cells in old age compared with aged wild-type (p53+/+) mice. We also assessed HSC dynamics in a p53 mutant mouse model (p53+/m) with higher apparent p53 activity than wild-type mice. The p53 hypermorphic (p53+/m) mice display phenotypes of premature aging. Many aged p53+/m organs exhibit reduced cellularity and atrophy, suggesting defects in stem-cell regenerative capacity. HSC numbers from old p53+/m mice fail to increase with age, unlike those of their p53+/+ and p53+/- counterparts. Moreover, transplantation of 500 HSCs from old p53+/m mice into lethally irradiated recipients resulted in reduced engraftment compared with old wild-type p53+/+ and p53+/- HSCs. Thus, alteration of p53 activity affects stem-cell numbers, proliferation potential, and hematopoiesis in older organisms, supporting a model in which aging is caused in part by a decline in tissue stem cell regenerative function.

[1]  K. Ligon,et al.  p16INK4a induces an age-dependent decline in islet regenerative potential , 2006, Nature.

[2]  R. DePinho,et al.  Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a , 2006, Nature.

[3]  S. Morrison,et al.  Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing , 2006, Nature.

[4]  T. Rando.  Stem cells, ageing and the quest for immortality , 2006, Nature.

[5]  F. Camargo,et al.  Hematopoietic stem cells do not engraft with absolute efficiencies. , 2006, Blood.

[6]  S. Helfand,et al.  Neuronal Expression of p53 Dominant-Negative Proteins in Adult Drosophila melanogaster Extends Life Span , 2005, Current Biology.

[7]  Ignacio Varela,et al.  Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation , 2005, Nature.

[8]  L. Donehower,et al.  p53 and Mouse Aging Models , 2005 .

[9]  Jichun Chen.  Senescence and functional failure in hematopoietic stem cells. , 2004, Experimental hematology.

[10]  K. Mohammad,et al.  Modulation of mammalian life span by the short isoform of p53. , 2004, Genes & development.

[11]  R. DePinho,et al.  Telomeres, stem cells, senescence, and cancer. , 2004, The Journal of clinical investigation.

[12]  P. Pelicci.  Do tumor-suppressive mechanisms contribute to organism aging by inducing stem cell senescence? , 2004, The Journal of clinical investigation.

[13]  G. van Zant,et al.  The role of stem cells in aging. , 2003, Experimental hematology.

[14]  Jichun Chen,et al.  Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. , 2003, Experimental hematology.

[15]  Robert M. Bachoo,et al.  Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing , 2003, Nature.

[16]  C. Deng,et al.  Senescence, aging, and malignant transformation mediated by p53 in mice lacking the Brca1 full-length isoform. , 2003, Genes & development.

[17]  J. Kanno,et al.  Serial Transplantation of p53-Deficient Hemopoietic Progenitor Cells to Assess Their Infinite Growth Potential , 2002, Experimental biology and medicine.

[18]  L. Donehower.  Does p53 affect organismal aging? , 2002, Journal of cellular physiology.

[19]  Hartmut Geiger,et al.  The aging of lympho-hematopoietic stem cells , 2002, Nature Immunology.

[20]  Stephen N. Jones,et al.  p53 mutant mice that display early ageing-associated phenotypes , 2002, Nature.

[21]  I. Weissman,et al.  Flk-2 is a marker in hematopoietic stem cell differentiation: A simple method to isolate long-term stem cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[23]  H. Vogel,et al.  Analysis of ku80-Mutant Mice and Cells with Deficient Levels of p53 , 2000, Molecular and Cellular Biology.

[24]  S. Elledge,et al.  Cancer: p53 sends nucleotides to repair DNA , 2000, Nature.

[25]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[26]  Lynda Chin,et al.  p53 Deficiency Rescues the Adverse Effects of Telomere Loss and Cooperates with Telomere Dysfunction to Accelerate Carcinogenesis , 1999, Cell.

[27]  G. de Haan,et al.  Dynamic changes in mouse hematopoietic stem cell numbers during aging. , 1999, Blood.

[28]  G. de Haan,et al.  Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. , 1997, Blood.

[29]  L. Donehower.  The p53-deficient mouse: a model for basic and applied cancer studies. , 1996, Seminars in cancer biology.

[30]  Y. Shounan,et al.  Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis. , 1996, Leukemia.

[31]  I. Weissman,et al.  The aging of hematopoietic stem cells , 1996, Nature Medicine.

[32]  C. Bucana,et al.  Long-term culture of lymphohematopoietic stem cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  A. S. Conner,et al.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo , 1996, The Journal of experimental medicine.

[34]  C. Purdie,et al.  Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. , 1994, Oncogene.

[35]  R. Weinberg,et al.  Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.

[36]  L. Donehower,et al.  Spontaneous and carcinogen–induced tumorigenesis in p53–deficient mice , 1993, Nature Genetics.

[37]  L. Donehower,et al.  In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. , 1993, Oncogene.

[38]  S. Nishikawa,et al.  Purification and characterization of heterogeneous pluripotent hematopoietic stem cell populations expressing high levels of c-kit receptor. , 1993, Blood.

[39]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[40]  M. Baert,et al.  Use of limiting-dilution type long-term marrow cultures in frequency analysis of marrow-repopulating and spleen colony-forming hematopoietic stem cells in the mouse. , 1991, Blood.

[41]  Edward L. Schneider,et al.  Handbook of the Biology of Aging , 1990 .

[42]  Mary Anne Wheeler,et al.  Stem , 1985 .

[43]  D. Harrison,et al.  Loss of stem cell repopulating ability upon transplantation. Effects of donor age, cell number, and transplantation procedure , 1982, The Journal of experimental medicine.

[44]  Fazekas de St Groth.  The evaluation of limiting dilution assays. , 1982, Journal of immunological methods.